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Background: The characteristics of new generation drug eluting stents (DES) are
the combination of thinner struts and fewer connectors. These may affect
longitudinal stent deformation. In tapered vessels, a diameter mismatch between
vessel and stent at the proximal edge could lead to longitudinal stent elongation
after fully stent expansion. The aim of this study was to analyze the longitudinal
integrity among different DESs.
Methods: Six different DESs (Cypher select, Taxus Liberte, Xience V, Nobori,
Taxus Element, and Endeavor) were examined using a tapered bench-top silicon
model. The diameter of each stents is 3.5mm and the length is 23 or 24mm. The
proximal stent edge was adjusted to 5mm away from the marker point of 4.0mm
in diameter. First, every stents were deployed at nominal pressure. Second, they
were dilated with the 4.0mm diameter non-compliant balloon at 10atm and 20atm
at the same condition. Intravascular ultrasound was used to measure the luminal
diameter and microscope was used to measure the longitudinal stent length of
their overall, the length from the marker point to the proximal stent edge, and the
uniformity of stent struts was evaluated. We used each three stents and their data
were averaged.
Results: Results show the table. The uniformity of stent struts were not kept in Taxus
Element stent.
stent length (mm)
DES pre deploy stent deploy
post balloon dilatation
at 10atm
post balloon
dilatation at 20atm
Cypher
select
23.550.05 24.030.06 (0.48) 24.050.27 (0.50) 24.390.11 (0.84)
Taxus
Liberte
25.270.18 24.800.21 (0.47) 25.150.11 (0.12) 25.340.35 (0.07)
Xience V 24.020.04 24.530.48 (0.51) 24.790.33 (0.77) 25.830.59 (1.81)
Nobori 24.790.02 24.890.17 (0.10) 25.070.12 (0.28) 25.460.16 (0.67)
Taxus
Element
23.080.19 23.160.03 (0.08) 23.910.39 (0.83) 24.530.38 (1.45)
Endeavor 25.090.02 25.570.04 (0.48) 25.550.01 (0.46) 26.320.35 (1.23)
Stent prox length from the marker point (mm)
stent deploy
post balloon
dilatation at 10atm
post balloon
dilatation at 20atm
5.690.21 (0.69) 5.550.37 (0.55) 6.160.21 (1.16)
5.180.29 (0.18) 5.500.15 (0.50) 5.730.31 (0.73)
5.670.37 (0.67) 6.080.26 (1.08) 7.000.52 (2.00)
5.160.21 (0.16) 5.390.52 (0.39) 6.140.25 (1.14)
5.120.18 (0.12) 5.810.34 (0.81) 6.420.08 (1.42)
5.170.09 (0.17) 5.450.13 (0.45) 6.160.58 (1.16)
Conclusions: Old generation DESs have more longitudinal strength than new generation
DESs. On the other hand, new generation DESs showed longitudinal stent elongation. We
should be careful when we use a new generation DESs, such as Xience V and Taxus
Element, for the treatment of the ostial lesion.
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Background: Recently, stent longitudinal deformation is becoming to be one of the
clinical issue. The objective of this study was to evaluate how post stent dilatation with
large balloon has an impact on stent elongation.
Methods: A Silicon tube modelwas used. Two types of drug eluting stents (Taxus
Element 3.0mm, Boston scientific, Massachusetts and Nobori 3.0mm, Terumo, Tokyo)
were deployed into the model as follows; 10mm of one side of the stent was attached to
the model wall and the 10mm on the opposite side of the stent was free from the vessel wall
(shown in Fig.1). Then, in both types of stents, post stent dilatation was performed with three
different types of 3.5mm balloon at rated balloon pressure as shown in Fig 2. A total of 6 stents
were tested, and stent length before and after post stent dilatation, difference of degree of stent
elongation between stent types and balloon types were measured.
Results: Stent elongation was observed in all stents, and the length of the stent free from
the model wall before and after post stent dilatation was 10.090.26mm and
11.510.66mm, respectively. There were no significant difference between the lengths
of the two types of stents (1.610.58 and 1.270.12, p0.36), but significant difference
between the three types of post stent balloons were found (1.110.02 and 1.120.00 and
1.190.04, p0.0063).
Conclusions: Stent elongation after post stent dilatation was observed in this ex vivo
model. Stent elongation after post stent dilatation may be influenced not only by stent type
but also the type of balloon used in post stent dilatation.
TCT-541
Coronary Computered Tomography for Systematic Screening of Coronary
Stent Fractures in Patients at High Risk
Lisa Krenn1, Vanessa Berger-Kulemann1, Philipp Krisai1, Florian Wolf1,
Georg Delle-Karth1, Gerhard Kreiner1, Clemens Gangl1, Markus Vertesich1,
Sabine Scherzer1, Christian Roth1, Irene Lang1, Heinz Sochor1,
Thomas Neunteufl1, Christian Loewe1, Berger Rudolf1
1Medical University of Vienna, Vienna, Austria
Background: Stent fractures (SFs) contribute to in-stent-restenosis and life-threatening
complications. Coronary computered tomography (CCT) may be an appropriate method
for the detection of a SF. Aim: This study prospectively evaluated the incidence of SFs in
high-risk patients using CCT and assessed the clinical relevance of this finding using
catheter coronary angiography (CCA).
Methods: Patients with two or more risk factors for a SF defined as (1) stent length 28
mm, (2) overlapping stents, (3) stent localization in the right coronary artery, or saphenous
vein graft and (4) vessel angulation 75° before implantation or stent angulation 45° after
implantation were invited to undergo a CCT 6 months after the procedure. To differentiate
between SF and overlap failure all stents were identified on the CCT image by measuring the
distance between edges and comparing these measurements with the known stent lengths. A
CCA was recommended in patients with a stent gap. Patients without stent gap but with
pathological findings in the CCT who underwent CCA served as controls.
Results: In 14 out of 41 patients (34%) coronary CCT revealed a stent gap including 8
patients with a SF (20%) and 6 patients with an overlap failure (15%). In the following
CCA all stent gaps were confirmed by optical coherence tomography. A clinically
relevant stent-related pathology could be detected in 4 out of 8 patients (50%) with SF
(in-stent-restenosis in two patients, chronic total occlusion and coronary aneurysm in one
patient, respectively), but in none out of 7 controls (chi-square – p0.001).
Conclusions: Stent gaps are frequent in high-risk patients. The majority of these gaps
result from a SF, which is often associated with a clinically relevant pathology. Therefore,
screening for SFs using CCT in high-risk patients might be beneficial.
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Background: Longitudinal stent deformation (i.e. the axial shortening or lengthening of
a stent after implantation) is increasingly reported. However, the axial integrity of stents
has not been systematically studied using intravascular ultrasound (IVUS).
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Methods: Consecutive patients who underwent IVUS analysis after drug-eluting stent
implantation for de novo lesions were evaluated. Stent length was studied using automatic
pullback of an IVUS catheter (Boston Scientific Corp/SCIMED, MN) and was further
analyzed for change in length (IVUS - label)(mm), the absolute change in length [|IVUS
– label|](mm), and the absolute value of the relative change in length [|(IVUS-label)|/
label](%).
Results: A total of 183 stents were included: 38.3% sirolimus-eluting stents (SES);
27.9% zotarolimus-eluting stents (ZES); 20.2% Co-Ch everolimus-eluting stents (Cc-
EES); 7.1% Pl-Ch everolimus-eluting stents (Pc-EES) - the Element platform and 6.6%
paclitaxel-eluting stents (PES). The change in stent length (mm) and the relative change
in length (%) differed between groups: SES 0.3 1.2; ZES 1.0 1.3; Cc-EES 0.6 1.0;
Pc-EES 0.4  1.1; PES 0.1  1.4 (p0.008) and SES 1.7  6.0; ZES 5.7  6.7;
Cc-EES 3.5 5.8; Pc-EES 2.3 6.0; PES2.2 8.1 (p0.001), respectively. Relative
change in stent length was higher in the ZES group in comparison with SES and PES
groups, (p 0.001 for both). There were no statistical differences between the Pc-EES
(Element) and any other stent types. The rate of absolute relative change 5% in stent
length was lower in the SES group compared to the other groups: SES 34%; ZES 63%;
Cc-EES 54%; Pc-EES 46%; and PES 67% (p0.02). Significant (15%) absolute
relative change in length was rare (3.8%) and did not differ between groups (p0.54).
Long stents (20 mm, n62) had a higher absolute change in length when compared to
other stent groups (18 mm, n50 and 16 mm, n71): 1.3 1.0 vs. 1.0 0.6 vs. 1.0 
0.6, respectively (p0.02).
Conclusions: IVUS analysis revealed that significant change in stent length after
implantation was rare in all stent types. Stent axial integrity was influenced by stent
length; longer stents displayed a higher absolute change in length than did shorter stents.
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Background: We report for the first time a specific pattern of stent strut fracture in
everolimus-eluting stents (EES).
Methods: We retrospectively analyzed 439 consecutive stented lesions in 364 pts who
underwent intravascular ultrasound (IVUS) during EES follow-up from January 2011 to
February 2012.
Results: EES fractures were observed in 13 Xience V stents in 9 RCAs, 3 SVGs, and 1
LAD; 7 stent fractures (53.8%) were located near the ostium. Two layers of stent struts
were present within the length of a single stent in 11 of 13 stent fractures (84.6%),
indicating that fracture was followed by partial longitudinal stent overlap (Figure). By
IVUS, a 36.1 10.7 % smaller stent area was observed at the fractured site compared to
the adjacent non-fracture site. Focal in-stent restenosis (defined as an in-stent minimum
lumen area  4mm2 that was 10mm in length) was observed at 12 fractured sites
(92%); and cardiac events occurred in 12 pts (92%: 2 NSTEMI without angiographic
thrombus and 12 target lesion revascularizations).
Conclusions: Partial strut fracture with Xience V EES may result in overlap of the stent
edges proximal and distal to the site of fracture.
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Background: Case series have reported LSD associated with a range mechanisms,
platforms and clinical events. To further elucidate mechanisms we amalgamated pub-
lished reports with additional unpublished cases.
Methods: We reviewed reports and angiographic images from 38 cases from 6 centres.
An additional, 5 published cases and procedural details from 57 cases published from the
MAUDE database were included. 20 published cases were excluded due to insufficient
details.
Results: In 100 cases, LSD most commonly involved LAD and RCA interventions (38
and 34 cases) and LMS intervention (13 cases) and less commonly circumflex and graft
interventions (5 and 8 cases). LSD was associated with the Element type platform in 78
cases and associated with Driver/Endeavor, Biomatrix/Nobori, Resolute, Xience, and
Cypher platforms in 7,4,3,3,3 cases. The mechanism of LSD was identified in 78 cases.
LSD of the proximal stent was induced by the guide catheter in 25 cases (33%), re-entry
by a balloon catheter in 30cases, and other equipment in 3 cases. LSD of the distal stent
was induced by equipment withdrawl in 20 cases (25 %) involving IVUS catheters, filter
devices, previously inflated balloons, trapped wires. Several cases of distal LSD involved
secondary guide induced proximal LSD when the guide was sucked in. Treatment
involved further stenting or reballooning in 66 and 22 cases; with 12 cases that were not
re-expanded. Adverse procedural outcome involving emergency CABG was reported in
2 cases, and stent thrombosis in 5 cases.
Conclusions: The commonest mechanisms causing LSD were guide catheter contact and
postdilation balloon re-entry, with a further 25 cases caused by equipment withdrawl.
LSD occurred uncommonly with circumflex and graft interventions. It was successfully
treated by reballooning and/or restenting in most cases, but with a 7% incidence of
MACE. The commonest stent platform was the element type platform.
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Background: Peri-stent contrast staining (PSS) was defined as contrast staining outside
the stent contour extending to20% of the stent diameter. PSS could be related to in-stent
restenosis and very late stent thrombosis. Furthermore PSS is linked to in-stent restenosis
and stent fracture. We evaluated the prevalence and clinical implications of PSS after
evelolimus-eluting stent(EES) comparing those of sirolimus-eluting stent (SES).
Methods: From November 2002 to September 2011, we treated 5239 lesions with SES
and 2119 lesions with EES. We evaluated the PSS after SES and EES implantation at
follow-up coronary angiography. Data are shown in the table. The incidence of in-stent
restenosis and stent fracture among the lesions with diagnosis of PSS was compared
between SES and DES.
Results: Data are shown in the table.
Conclusions: The clinical implication of PSS after EES implantation was quite different
from those of SES implantation.
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